Tweet
Have anyone her tries the NEB small RNA library prep kit?
How is the result compared to the Illumina TruSeq?
How is the result compared to the Illumina TruSeq?
-
-
There is more info in this thread: http://seqanswers.com/forums/showthread.php?t=60379
Generally both gives similar results down to 2ng miRNA input (fraction of miRNA in total RNA) with a similar workflow but NEB kit costs less. -
Bioo Scientific also offers a similar kit which uses adapters with randomized ends to reduce ligase bias. The issue of ligase bias is pretty well known in the small RNA library prep field, feel free to PM me for more information. I was hesitant to post here because I don't want it to look like a sales pitch, but I truly believe the use of randomized adapters is the way to go with small RNA library prep.
As a disclaimer, I work for Bioo Scientific.Comment
-
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM
Comment